| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 9, 219-231, Copyright © 1995 by Endocrine Society
ARTICLES |
G Krey, A Mahfoudi and W Wahli
Institut de Biologie Animale, Universite de Lausanne, Switzerland.
Peroxisome proliferator-activated receptor (PPARs) are members of the nuclear receptor superfamily. For transcriptional activation of their target genes, PPARs heterodimerize with the retinoid-X receptor (RXR). The convergence of the PPAR and RXR signaling pathways has been shown to have an important function in lipid metabolism. The promoter of the gene encoding the acyl-coenzyme-A oxidase (ACO), the rate-limiting enzyme in peroxisomal beta-oxidation of fatty acids, is a target site of PPAR action. In this study, we examined the role and the contribution of both cis-and trans-acting factors in the transcriptional regulation of this gene using transient transfections in insect cells. We identified several functional cis-acting elements present in the promoter of the ACO gene and established that PPAR- dependent as well as PPAR-independent mechanisms can activate the ACO promoter in these cells. We show that the PPAR/RXR heterodimer exerts its effect through two response elements within the ACO promoter, in synergy with the transcription factor Sp1 via five Sp1-binding sites. Furthermore, this functional interaction also occurs when Sp1 is co- expressed with PPAR or RXR alone, indicating that activation can occur independently of PPAR/RXR heterodimers.
This article has been cited by other articles:
![]() |
V Costa, D Foti, F Paonessa, E Chiefari, L Palaia, G Brunetti, E Gulletta, A Fusco, and A Brunetti The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-{gamma} (PPAR{gamma}) and thiazolidinedione-PPAR{gamma} agonists Endocr. Relat. Cancer, March 1, 2008; 15(1): 325 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nielsen, L. Grontved, H. G. Stunnenberg, and S. Mandrup Peroxisome Proliferator-Activated Receptor Subtype- and Cell-Type-Specific Activation of Genomic Target Genes upon Adenoviral Transgene Delivery Mol. Cell. Biol., August 1, 2006; 26(15): 5698 - 5714. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Deng, S. Shan, P.-P. Li, Z.-F. Shen, X.-P. Lu, J. Cheng, and Z.-Q. Ning Peroxisome Proliferator-Activated Receptor-{gamma} Transcriptionally Up-Regulates Hormone-Sensitive Lipase via the Involvement of Specificity Protein-1 Endocrinology, February 1, 2006; 147(2): 875 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, P. A. Hansen, L. Xi, R. A. S. Chandraratna, and C. F. Burant Distinct Mechanisms of Glucose Lowering by Specific Agonists for Peroxisomal Proliferator Activated Receptor {gamma} and Retinoic Acid X Receptors J. Biol. Chem., November 18, 2005; 280(46): 38317 - 38327. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Han, H. N. Rivera, and J. Roman Peroxisome Proliferator-Activated Receptor-{gamma} Ligands Inhibit {alpha}5 Integrin Gene Transcription in Non-Small Cell Lung Carcinoma Cells Am. J. Respir. Cell Mol. Biol., April 1, 2005; 32(4): 350 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Zhou and C.-M. Chiang Sp1 and AP2 regulate but do not constitute TATA-less human TAFII55 core promoter activity Nucleic Acids Res., October 1, 2002; 30(19): 4145 - 4157. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Delerive, K. De Bosscher, W. Vanden Berghe, J.-C. Fruchart, G. Haegeman, and B. Staels DNA Binding-Independent Induction of I{kappa}B{alpha} Gene Transcription by PPAR{alpha} Mol. Endocrinol., May 1, 2002; 16(5): 1029 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rodríguez, V. Noé, A. Cabrero, C. J. Ciudad, and J. C. Laguna Differences in the Formation of PPARalpha -RXR/acoPPRE Complexes between Responsive and Nonresponsive Species upon Fibrate Administration Mol. Pharmacol., July 1, 2000; 58(1): 185 - 193. [Abstract] [Full Text] |
||||
![]() |
S. D Clarke, P. Thuillier, R. A Baillie, and X. Sha Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors Am. J. Clinical Nutrition, October 1, 1999; 70(4): 566 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Desvergne and W. Wahli Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism Endocr. Rev., October 1, 1999; 20(5): 649 - 688. [Abstract] [Full Text] |
||||
![]() |
V. Giguère Orphan Nuclear Receptors: From Gene to Function Endocr. Rev., October 1, 1999; 20(5): 689 - 725. [Abstract] [Full Text] |
||||
![]() |
P. Bernard, H. Goudonnet, Y. Artur, B. Desvergne, and W. Wahli Activation of the Mouse TATA-less and Human TATA-Containing UDP-Glucuronosyltransferase 1A1 Promoters by Hepatocyte Nuclear Factor 1 Mol. Pharmacol., September 1, 1999; 56(3): 526 - 536. [Abstract] [Full Text] |
||||
![]() |
I. Barroso and P. Santisteban Insulin-induced Early Growth Response Gene (Egr-1) Mediates a Short Term Repression of Rat Malic Enzyme Gene Transcription J. Biol. Chem., June 18, 1999; 274(25): 17997 - 18004. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Näär, P. A. Beaurang, K. M. Robinson, J. D. Oliner, D. Avizonis, S. Scheek, J. Zwicker, J. T. Kadonaga, and R. Tjian Chromatin, TAFs, and a novel multiprotein coactivator are required for synergistic activation by Sp1 and SREBP-1a in vitro Genes & Dev., October 1, 1998; 12(19): 3020 - 3031. [Abstract] [Full Text] |
||||
![]() |
E. Jeannin, D. Robyr, and B. Desvergne Transcriptional Regulatory Patterns of the Myelin Basic Protein and Malic Enzyme Genes by the Thyroid Hormone Receptors alpha 1 and beta 1 J. Biol. Chem., September 11, 1998; 273(37): 24239 - 24248. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. H. Yan, W. G. Karam, J. L. Staudinger, A. Medvedev, B. I. Ghanayem, and A. M. Jetten Regulation of Peroxisome Proliferator-activated Receptor alpha -Induced Transactivation by the Nuclear Orphan Receptor TAK1/TR4 J. Biol. Chem., May 1, 1998; 273(18): 10948 - 10957. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.M. NAAR, S. RYU, and R. TJIAN Cofactor Requirements for Transcriptional Activation by Sp1 Cold Spring Harb Symp Quant Biol, January 1, 1998; 63(0): 189 - 200. [Abstract] [PDF] |
||||
![]() |
C. Juge-Aubry, A. Pernin, T. Favez, A. G. Burger, W. Wahli, C. A. Meier, and B. Desvergne DNA Binding Properties of Peroxisome Proliferator-activated Receptor Subtypes on Various Natural Peroxisome Proliferator Response Elements. IMPORTANCE OF THE 5'-FLANKING REGION J. Biol. Chem., October 3, 1997; 272(40): 25252 - 25259. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. B. de Medeiros, G. Krey, A. K. Hihi, and W. Wahli Functional Interactions between the Estrogen Receptor and the Transcription Activator Sp1 Regulate the Estrogen-dependent Transcriptional Activity of the Vitellogenin A1 io Promoter J. Biol. Chem., July 18, 1997; 272(29): 18250 - 18260. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ren, A. Thelen, and D. B. Jump Peroxisome Proliferator-activated Receptor alpha Inhibits Hepatic S14 Gene Transcription. EVIDENCE AGAINST THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR alpha AS THE MEDIATOR OF POLYUNSATURATED FATTY ACID REGULATION OF S14 GENE TRANSCRIPTION J. Biol. Chem., July 19, 1996; 271(29): 17167 - 17173. [Abstract] [Full Text] [PDF] |
||||
![]() |
R P Brun, P Tontonoz, B M Forman, R Ellis, J Chen, R M Evans, and B M Spiegelman Differential activation of adipogenesis by multiple PPAR isoforms. Genes & Dev., April 15, 1996; 10(8): 974 - 984. [Abstract] [PDF] |
||||
![]() |
T. C. Leone, S. Cresci, M. E. Carter, Z. Zhang, D. S. Lala, A. W. Strauss, and D. P. Kelly The Human Medium Chain Acyl-CoA Dehydrogenase Gene Promoter Consists of a Complex Arrangement of Nuclear Receptor Response Elements and Sp1 Binding Sites J. Biol. Chem., July 7, 1995; 270(27): 16308 - 16314. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Horie, H. Ishii, F. Matsumoto, M. Kusano, K. Kizaki, J. Matsuda, and M. Kazama Acceleration of Thrombomodulin Gene Transcription by Retinoic Acid. RETINOIC ACID RECEPTORS AND Sp1 REGULATE THE PROMOTER ACTIVITY THROUGH INTERACTIONS WITH TWO DIFFERENT SEQUENCES IN THE 5'-FLANKING REGION OF HUMAN GENE J. Biol. Chem., January 19, 2001; 276(4): 2440 - 2450. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |